vision changes with tirzepatide Comparative ocular outcomes of versus other anti-obesity medications in people obesity tirzepatide and blurry vision issues

Fawcett, D

In the future it will be interesting to see whether a single small molecule can target multiple family B GPCR receptors

(2015) KEYNOTE-006 investigators

Saxenda was the first GLP-1 medication to get approval from the FDA for weight management in adults with obesity and overweight with at least one weight-related health condition as an adjunct to exercise, and lifestyle and dietary modifications

Some athletes who train in the evening shift their injection day to a rest day entirely, which avoids the overlap problem

If you are thinking about adding phentermine to tirzepatide , understand that this combination has limited research support and the cardiovascular implications are not well studied